“…Studies in other SCCs have shown that p16 INK4A expression measured by immunohistochemistry correlates well with HPV positivity ( Mellin Dahlstrand et al , 2005 ; Santos et al , 2006 ; Reimers et al , 2007 ; Fuste et al , 2010 ), making it a useful biomarker for HPV-related oncogenic activity and malignant transformation in cervix, vulva, and vagina ( Klaes et al , 2001 ; O'neill and Mccluggage, 2006 ; Fuste et al , 2010 ). In the cervix p16 INK4A has proven as useful in identifying dysplasia, and correlates with the severity of dysplasia ( Norman et al , 2007 ). In the cervix and other sites, it has also been demonstrated to be of prognostic significance ( Masoudi et al , 2006 ; Reimers et al , 2007 ; Schwarz et al , 2012 ).…”